Log In
Print
BCIQ
Print
Print this Print this
 

dexmethylphenidate (Focalin XR)

Also known as: formerly Focalin LA

  Manage Alerts
Collapse Summary General Information
Company Celgene Corp.
DescriptionD-enantiomer of methylphenidate hydrochloride
Molecular Target Unknown
Mechanism of ActionUnknown
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentMarketed
Standard IndicationAttention deficit hyperactivity disorder (ADHD)
Indication DetailsTreat attention deficit hyperactivity disorder (ADHD)
Regulatory Designation

Partner

Novartis AG


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today